DA

Dipaksinh Ajitsinh Rathod

Active Director Director DIN 09660522
DIN 09660522 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipaksinh Ajitsinh Rathod

Data last updated:

Dipaksinh Ajitsinh Rathod is a Director at Beyond Cure Private Limited (since 2022). The company operates in Chemicals.

DIN 09660522
Primary Designation Director
Industry Chemicals
First Appointment 01 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beyond Cure Private Limited U24290GJ2022PTC133496
Director01 Jul 20222022Active

Board colleagues of Dipaksinh Ajitsinh Rathod

Directorship timeline

Open interactive timeline →
Beyond Cure Private Limited
Premium access

Shareholding and investment profile for Dipaksinh Ajitsinh Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipaksinh Ajitsinh Rathod

Dipaksinh Ajitsinh Rathod currently holds 1 directorship: Beyond Cure Private Limited (Director, since 01 Jul 2022).

Dipaksinh Ajitsinh Rathod was first appointed on 01 Jul 2022 as Director at Beyond Cure Private Limited.

The current boards of Dipaksinh Ajitsinh Rathod's companies include Avinash Prahladbhai Nandgavakar (Beyond Cure Private Limited), Brijeshkumar Virendrakumar Raval (Beyond Cure Private Limited), Satyakam Nitinbhai Joshi (Beyond Cure Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available